Covered recipient · General Payments record
DEREK MASON WEDEL
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2024
$174.56
- Reported across 11 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $174.56 | 11 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $42.57 | 3 |
| PFIZER INC. | $35.10 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $34.60 | 2 |
| Lilly USA, LLC | $33.41 | 2 |
| E.R. Squibb & Sons, L.L.C. | $15.27 | 1 |
| Amgen Inc. | $13.61 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2024 | $174.56 | 11 |
Payment records · PY2024 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $13.61 | 06/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111737338 | CMS |
| E.R. Squibb & Sons, L.L.C. | $15.27 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101546118 | CMS |
| Lilly USA, LLC | $15.53 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136167846 | CMS |
| Lilly USA, LLC | $17.88 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136167848 | CMS |
| Novartis Pharmaceuticals Corporation | $13.87 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087437808 | CMS |
| Novartis Pharmaceuticals Corporation | $20.73 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087437834 | CMS |
| Novo Nordisk Inc | $14.14 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097502837 | CMS |
| Novo Nordisk Inc | $13.83 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097251363 | CMS |
| Novo Nordisk Inc | $14.60 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096601627 | CMS |
| PFIZER INC. | $18.13 | 10/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131931463 | CMS |
| PFIZER INC. | $16.97 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132109059 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2024
- Source files
- Dataset page · Bulk file · PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.